Kemarut C. Laothamatas, MD

Dr. DiMango is Director of the Columbia University Gunnar Esiason Adult Cystic Fibrosis (CF) Program and the Asthma Research Program. The adult CF program cares for nearly 300 people with CF, with support from a dedicated multi-disciplinary team. She is co-Director of the Cystic Fibrosis Foundation Therapeutics Development Network at Columbia. She currently serves as Principal Investigator for numerous research projects in the areas of cystic fibrosis and asthma. Dr. DiMango currently serves as the national Chair of the Cystic Fibrosis Foundation (CFF) Therapeutics Development Network Program Protocol Review Committee.

Gabriel Rand, MD, is Assistant Professor of Ophthalmology at CUMC, and a board-certified cornea expert specializing in the medical and surgical management of cornea, anterior segment, and refractive conditions. Dr. Rand received his fellowship training in cornea, anterior segment, and refractive surgery at Columbia University Irving Medical Center. He has an undergraduate degree from the School of Engineering at Cornell University and completed his medical school and ophthalmology residency at the Albert Einstein College of Medicine. During his residency, Dr. Rand was awarded the Ronald M. Burde Award for Excellence in Research for his work in the application of advanced statistical methods with eye bank data. Dr. Rand will be seeing patients in Columbia Ophthalmology's Westchester practice and the Edward S. Harkness Eye Institute in northern Manhattan.

Lisa A. Kachnic, MD, one of the nation’s leading radiation oncologists and a pioneer of new approaches to optimize the effectiveness of radiation therapy, is the Chu H. Chang Professor and Chief of the Department of Radiation Oncology at Columbia University Vagelos College of Physicians and Surgeons (VP&S) and Chief of the Radiation Oncology Service at NewYork-Presbyterian/Columbia University Irving Medical Center (CUIMC). She also serves as Associate Director of Radiation Oncology and Science in the Herbert Irving Comprehensive Cancer Center (HICCC). Dr. Kachnic’s combined focus on clinical excellence, technological innovation, and patient-centered research continues to advance the field of radiation oncology, which has resulted in over 150 publications and over $17 million in research support from major federal and non-profit agencies. She is widely recognized for gastrointestinal research that has transformed the standard of care for several cancers by integrating novel radiation delivery techniques. A past president of the American Board of Radiology, Dr. Kachnic is internationally known for her clinical trial leadership positions in the National Cancer Institute and its cooperative group research bases. She currently serves as Vice Chair of the Radiation Oncology Committee and Co-Chair of the Ano-Rectal Subcommittee for the SWOG Cancer Research Network research base, for which she is the multi-modality executive officer, as well as NRG Oncology’s Associate PI of their NCORP (NCI Community Oncology Research Program) and chair of the NCORP’s Cancer Control Committee. At Columbia, she is contact PI of Columbia’s NCORP and is co-PI of several NCI training grants for residents and early career faculty.